SCHEMBL2345082

SCHEMBL2345082

Brc1ccc(-n2c(N3CCNCC3)cc3ccccc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR3E A5X5Y0 3/20 0.48
▸ HTR3B O95264 3/20 0.48
▸ HTR3A P46098 3/20 0.48
▸ HTR3D Q70Z44 3/20 0.48
▸ HTR3C Q8WXA8 3/20 0.48
▸ SIGMAR1 Q99720 3/20 0.48
▸ HTR5A P47898 2/20 0.48
▸ HTR2A P28223 3/20 0.41
▸ HTR2C P28335 2/20 0.41
▸ KDR P35968 1/20 0.41
▸ ADRB1 P08588 1/20 0.40
▸ ESRRB O95718 3/20 0.39
▸ ESRRA P11474 3/20 0.39
▸ ESRRG P62508 3/20 0.39
▸ HTR6 P50406 2/20 0.38
▸ HTR1A P08908 2/20 0.38
▸ HTR7 P34969 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ NCF1 P14598 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11555106 0.88 HTR3E (0.53) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL2346369 0.86 ADRB1 (0.53) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL2348309 0.83 HTR3A (0.44) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL2342043 0.83 HTR3A (0.56) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL2345155 0.78 HTR1A (0.44) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL2346242 0.78 ADRB1 (0.60) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL2343308 0.78 SOS1 (0.47) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL2348220 0.76 ADRB1 (0.62) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL4309788 0.76 PKM (0.45) HTR6LMNA
SCHEMBL2350412 0.75 HTR6 (0.63) HTR3EHTR3BHTR3AHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8008491-B2 poly(adenosine 5'-diphosphate ribose) polymerase inhibitors such as 1-phenyl-2-(piperazin-1-yl)-1,3-dihydropyrrolo[2,3-b]pyridine-3-carboxaldehyde, used in the treatment and/or prevention central nervous system and cardiovascular disorders AVENTIS PHARMACEUTICALS, INC. (US) 2011-08-30 — — US disclosed
Send feedback